Aculys Pharma and SUSMED Have Entered into a Contract to Conduct the World's First Clinical Trial Utilizing Blockchain Technology

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Hamamatsucho ,Tokyo ,Japan ,Minato Ku ,Aichi ,Shibaura ,Chuo Ku ,Japanese ,Toru Fujieda ,Aculys Pharma ,Kazunari Tsunaba ,Brains Company Inc ,Co Ltd ,Contract Research Organization ,Data Base Of The European Medicines Agency ,Ministry Of Health ,Aculys Pharma Inc ,Susmed Inc ,Cabinet Office ,National Cancer Center ,Pr Group ,Taro Ueno ,International Medical Journal ,Source Data Verification ,Data Base ,National Library ,National Institutes ,Trials Register ,European Medicines Agency ,Special Measures ,Hamamatsucho Bldg ,Pharma Public Relations Secretariat ,Brains Company ,Business Wire ,Technology ,Health ,Blockchain ,Clinical Trials ,Business ,